Differences in cancer outcome definitions across trials were addressed by grouping clinically equivalent endpoints (e.g., hepatocellular carcinoma and primary liver cancer) and accounting for heterogeneity through random-effects modeling, sensitivity analyses, and GRADE downgrading for indirectness where appropriate
The first is getting more healthcare professionals to recognize obesity, to treat it as a chronic disease, and be willing to write prescriptions for it, along with recommending diet and exercise
But heres what we know from recent research: A 2025 study presented at ENDO showed that postmenopausal women using tirzepatide plus hormone replacement therapy (HRT) lost significantly more weight (17% total body weight) compared to women using tirzepatide alone (14%)
Knowing how to assess the situation and whether your medication is still viable prevents unnecessary waste and unnecessary risk
Black Ginger Extract As an example, in a recent episode of my Vitamin Professor podcast (brought to you by VRM Media), I interviewed the brilliant Dr
severe and disabling arthralgia